Wilmington, MA, United States of America

Michael Dore



 

Average Co-Inventor Count = 10.8

ph-index = 4

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: The Innovative Mind of Michael Dore

Introduction

Michael Dore, hailing from Wilmington, MA, has established himself as a significant contributor to the field of pharmaceutical research and innovation. With a total of six patents to his name, Dore is recognized for his inventive work that aims to address critical health issues through innovative compounds and compositions.

Latest Patents

Among his latest inventions are novel compounds designed for inhibiting the activity of SHP2, a protein involved in various diseases. This innovative work includes compounds of formula I, specifically focusing on N-azaspirocycloalkane substituted N-heteroaryl compounds. Dore's inventions not only define a new class of compounds with potential therapeutic applications but also encompass processes for their preparation and pharmaceutical formulations. These innovations present promising avenues for managing diseases associated with the aberrant activity of SHP2.

Career Highlights

Michael Dore's career is marked by his affiliation with Novartis AG, a company known for its commitment to advancing healthcare through scientific discovery. Dore has played a pivotal role in his field, leveraging his expertise to develop groundbreaking solutions that enhance patient care.

Collaborations

Collaboration has been a key aspect of Dore's work. He works alongside talented individuals such as Zhuoliang Chen and Jorge Garcia Fortanet, whose combined expertise fosters an environment rich in innovation and creativity. Together, they contribute to the broader goals of their research initiatives, pushing the boundaries of what is possible in medical science.

Conclusion

Michael Dore stands out as an inventor whose contributions are not only significant in terms of patents but also impactful in the realm of healthcare. His work in developing compounds that inhibit SHP2 activity underscores the importance of innovation in addressing complex medical challenges. As he continues to collaborate and innovate, Dore's legacy is poised to advance the field of pharmaceutical research further, benefiting countless patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…